Search

Your search keyword '"Pienta, Kenneth"' showing total 2,554 results

Search Constraints

Start Over You searched for: Author "Pienta, Kenneth" Remove constraint Author: "Pienta, Kenneth"
2,554 results on '"Pienta, Kenneth"'

Search Results

1. Precision Adaptive Hormone Control for Personalized Metastatic Prostate Cancer Treatment

2. Biochemical recurrence in patients with prostate cancer after primary definitive therapy: treatment based on risk stratification.

3. Application of next-generation imaging in biochemically recurrent prostate cancer.

10. Neuropilin-2 regulates androgen-receptor transcriptional activity in advanced prostate cancer

11. Prostate-Specific Membrane Antigen PET Response Associates with Metastasis-Free Survival After Stereotactic Ablative Radiation in Oligometastatic Prostate Cancer

13. Prostate cancer research in the 21st century; report from the 2021 Coffey‐Holden prostate cancer academy meeting

15. The Mutational Landscape of Metastatic Castration-sensitive Prostate Cancer: The Spectrum Theory Revisited

17. Neoadjuvant enoblituzumab in localized prostate cancer: a single-arm, phase 2 trial

21. A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with 18F-DCFPyL in Prostate Cancer Patients (OSPREY).

22. Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer

24. Identifying key questions in the ecology and evolution of cancer

25. Characterization of extracellular vesicles and synthetic nanoparticles with four orthogonal single‐particle analysis platforms

27. Meeting report from the Prostate Cancer Foundation PSMA theranostics state of the science meeting

28. Prostate cancer research: The next generation; report from the 2019 Coffey‐Holden Prostate Cancer Academy Meeting

29. Gleason pattern 5 is associated with an increased risk for metastasis following androgen deprivation therapy and radiation: An analysis of RTOG 9202 and 9902

30. WNT Pathway Mutations in Metachronous Oligometastatic Castration-Sensitive Prostate Cancer

46. Integrin alpha V beta 3 targeted dendrimer‐rapamycin conjugate reduces fibroblast‐mediated prostate tumor progression and metastasis

47. CXCL12γ Promotes Development of Metastatic Castration Resistant Prostate Cancer by Induction of Cancer Stem Cell and Neuroendocrine Phenotypes

50. Prostate-specific membrane antigen PET response associates with metastasis-free survival following stereotactic ablative radiation in oligometastatic prostate cancer

Catalog

Books, media, physical & digital resources